Q13133 | SWISS-MODEL Repository

447 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 4 identical sequences: Homo sapiens: F1D8N1; Pan troglodytes: K7AUZ1, A0A6D2XX46; Pan paniscus: A0A2R9BV37

It is possible new templates exist for this target since these models were created.

Description	PDB ID	Oligo-state	Range	Ligands
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 32b	5avl SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	204-447	2×4KQ;
Assess
Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4	5avi SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	204-446	2×4KM;
Assess
Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	5hjs SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	205-446	2×668; 2×SO4;
Assess
X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha	3ips SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	205-446	2×SO4; 2×O90;
Assess
X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha	3ipu SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	204-445	2×O40; 2×SO4;
Assess
X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha	3ipq SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer Q15788;	205-445	2×965; 2×SO4;
Assess
Crystal structure of the LXRalfa-RXRbeta LBD heterodimer	1uhl SMTL PDBe PDBe-KB PDBj PDBsum RCSB	Heteromer P28702; Q15596;	207-445	1×MEI; 1×444;
Assess

Template	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
4nqa.1.B	monomer	0.74	85-444	2×ZN;	73.70
Assess
4nqa.2.B	monomer	0.74	86-445	2×ZN; 1×965;	73.70
Assess
5uan.1.B	monomer	0.66	97-444	1×ZN;	34.23
Assess
7wnh.4.A	monomer	0.61	98-444	1×ZN;	29.43
Assess
7wnh.2.A	monomer	0.61	97-443	2×ZN;	29.43
Assess
3dzy.1.B	monomer	0.61	95-445	1×ZN;	28.65
Assess
4iqr.2.A	monomer	0.58	96-444	2×ZN;	30.72
Assess
4iqr.2.B	monomer	0.57	96-444	2×ZN;	30.72
Assess
7prw.1.B	monomer	0.57	95-446	2×ZN;	24.25
Assess
5uan.1.A	monomer	0.53	97-430	1×ZN;	31.49
Assess
3dzy.1.A	monomer	0.52	95-430	2×ZN;	31.09
Assess
4nqa.2.A	monomer	0.52	97-430	1×ZN;	31.49
Assess

Model ID	Oligo-state	Avg pLDDT	Range	Trg-Mdl Seq Id (%)

Model ID	Oligo-state	Avg Confidence	Range	Trg-Mdl Seq id (%)

Template	Isoform	Oligo-state	QMEANDisCo	Range	Ligands	Trg-Tpl Seq id (%)
Isoform 2	4nqa.1.B	monomer	0.67	85-384	2×ZN;	68.65
Assess
Isoform 2	4nqa.2.B	monomer	0.65	86-385	2×ZN;	68.65
Assess
Isoform 2	5uan.1.B	monomer	0.64	97-384	1×ZN;	30.82
Assess
Isoform 2	7wnh.2.A	monomer	0.59	97-383	2×ZN;	27.68
Assess
Isoform 2	4iqr.1.B	monomer	0.58	96-384	2×ZN;	28.87
Assess
Isoform 2	4iqr.2.A	monomer	0.58	96-384	2×ZN;	28.87
Assess
Isoform 2	3dzy.1.A	monomer	0.57	95-383	2×ZN;	26.96
Assess
Isoform 2	3dzy.1.B	monomer	0.56	95-385	1×ZN;	28.37
Assess
Isoform 2	7wnh.4.A	monomer	0.56	98-384	1×ZN;	27.68
Assess
Isoform 2	7prw.1.A	monomer	0.55	95-386	2×ZN;	22.68
Assess
Isoform 2	7prv.1.B	monomer	0.54	95-386	2×ZN;	22.68
Assess
Isoform 3	4nqa.1.B	monomer	0.74	40-399	2×ZN;	73.70
Assess
Isoform 3	4nqa.2.B	monomer	0.74	41-400	2×ZN; 1×965;	74.38
Assess
Isoform 3	5uan.1.B	monomer	0.66	52-399	1×ZN;	34.23
Assess
Isoform 3	7wnh.4.A	monomer	0.62	53-400	1×ZN;	29.04
Assess
Isoform 3	7wnh.2.A	monomer	0.62	52-398	2×ZN;	29.04
Assess
Isoform 3	3dzy.1.B	monomer	0.61	50-399	1×ZN;	28.94
Assess
Isoform 3	4iqr.2.B	monomer	0.59	51-399	2×ZN;	31.03
Assess
Isoform 3	4iqr.2.A	monomer	0.58	51-399	2×ZN;	31.03
Assess
Isoform 3	7prv.1.B	monomer	0.58	50-401	2×ZN;	24.25
Assess
Isoform 3	3dzy.1.A	monomer	0.53	50-385	2×ZN;	30.25
Assess
Isoform 3	5uan.1.A	monomer	0.53	52-385	1×ZN;	31.49
Assess
Isoform 3	4nqa.2.A	monomer	0.52	52-385	1×ZN;	31.49
Assess